Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Sell
4,975
-1,582
-24% -$70.7K 0.01% 556
2026
Q1
$316K Sell
6,557
-22
-0.3% -$1.03K 0.02% 379
2025
Q4
$319K Buy
6,579
+295
+5% +$14.6K 0.02% 367
2025
Q3
$297K Sell
6,284
-358
-5% -$17.3K 0.02% 378
2025
Q2
$321K Sell
6,642
-783
-11% -$40K 0.02% 336
2025
Q1
$412K Buy
7,425
+716
+11% +$38.8K 0.03% 248
2024
Q4
$324K Buy
6,709
+66
+1% +$3.36K 0.03% 277
2024
Q3
$383K Buy
6,643
+200
+3% +$10.8K 0.03% 241
2024
Q2
$313K Buy
6,443
+234
+4% +$11.3K 0.03% 247
2024
Q1
$302K Buy
6,209
+479
+8% +$23.4K 0.03% 259
2023
Q4
$285K Sell
5,730
-832
-13% -$40.7K 0.03% 244
2023
Q3
$352K Buy
6,562
+364
+6% +$19.4K 0.05% 190
2023
Q2
$334K Buy
6,198
+345
+6% +$18.6K 0.04% 192
2023
Q1
$319K Buy
+5,853
New +$285K 0.04% 185

Other funds holding SNY

PDS Planning's SNY Position: Q2 2026 in Review

PDS Planning reduced its Sanofi (SNY) stake by 24% in Q2 2026, selling an estimated $70.7K and leaving 4,975 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #556.

PDS Planning first reported a position in SNY in Q1 2023 and has held it in 14 quarters since. The position peaked at $412K in Q1 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • PDS Planning held 4,975 shares of Sanofi worth $212K as of Q2 2026.
  • PDS Planning sold 1,582 Sanofi shares in Q2 2026, an estimated $70.7K.
  • Sanofi made up 0.01% of PDS Planning's portfolio in Q2 2026, its #556 holding.
  • PDS Planning first reported a position in Sanofi in Q1 2023 and has held it in 14 quarters since.
  • PDS Planning's Sanofi position peaked at $412K in Q1 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on PDS Planning's 13F filing for Q2 2026, filed 5 Aug 2026.